SCHEMBL8188956

SCHEMBL8188956

CCOC(=O)C1=Cc2cc(OC)ccc2N=C(N)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 5/20 0.53
TLR7 Q9NYK1 1/20 0.53
CA12 O43570 2/20 0.43
CA9 Q16790 2/20 0.43
CA2 P00918 1/20 0.43
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
KDM4E B2RXH2 4/20 0.42
PRKCZ Q05513 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
MAPT P10636 3/20 0.41
HSD17B10 Q99714 2/20 0.41
MEN1 O00255 1/20 0.41
TP53 P04637 1/20 0.41
CASP3 P42574 1/20 0.41
KMT2A Q03164 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10326201 0.91 TLR8 (0.56) TLR8TLR7ALDH1A1HPGDKDM4E
SCHEMBL8179545 0.91 TLR8 (0.60) TLR8TLR7CA12CA9ALDH1A1
SCHEMBL10326042 0.88 TLR8 (0.61) TLR8TLR7ALDH1A1HPGDKDM4E
SCHEMBL8179510 0.88 CA12 (0.55) TLR8TLR7CA12CA9CA2
SCHEMBL7509353 0.85 TLR8 (0.54) TLR8TLR7ALDH1A1HPGDKDM4E
SCHEMBL10325225 0.84 TLR8 (0.53) TLR8TLR7ALDH1A1KDM4ENPC1
SCHEMBL8188907 0.84 CA12 (0.41) TLR8CA12CA9CA2ALDH1A1
SCHEMBL8179986 0.83 TLR8 (0.54) TLR8TLR7ALDH1A1HPGDKDM4E
SCHEMBL10343253 0.83 TLR8 (0.62) TLR8TLR7
SCHEMBL10325490 0.82 TLR8 (0.59) TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6043238-A 2-Aminobenzazapine derivatives PFIZER INC. (US) 2000-03-28 US disclosed
EP-0825186-A1 2-Aminobenzazepine derivatives and their use for the treatment of immunosuppression PFIZER INC. (US) 1998-02-25 EP disclosed